Thalamus Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Olutasidenib and Temozolomide in HGG (NCT06161974) | Rigel Pharmaceuticals | 2025-02-01 |
Track Thalamus Tumor automatically
Every clearance here is in the API, with alerts when new ones post.